Soleno Therapeutics to Participate in Upcoming Conferences

Soleno Therapeutics (NASDAQ: SLNO) will participate in three investor conferences in Feb–Mar 2026: Guggenheim Emerging Outlook: Biotech Summit, Oppenheimer 36th Annual Healthcare Life Sciences Conference, and TD Cowen 46th Annual Health Care Conference.

Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO) will participate in three investor conferences in Feb–Mar 2026: Guggenheim Emerging Outlook: Biotech Summit, Oppenheimer 36th Annual Healthcare Life Sciences Conference, and TD Cowen 46th Annual Health Care Conference.

Presentations are scheduled Feb 12 (11:30 AM ET, fireside chat), Feb 26 (10:00 AM ET, company presentation) and Mar 4 (9:50 AM ET, fireside chat). Webcasts and replays will be available in the company’s Investors section at www.soleno.life.

Argus Jan 29 session

-2.52% close to close Open Argus

Details

News Market Reaction – SLNO

In the Jan 29 session, SLNO declined 2.52%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Soleno’s participation in three upcoming investor conferences in February ...

Analysis

This announcement details Soleno’s participation in three upcoming investor conferences in February and March, including sessions at Guggenheim, Oppenheimer, and TD Cowen with scheduled presentation times. It follows recent milestones such as preliminary 2025 VYKAT XR revenue of $189M–$191M, profitability, and a $100M accelerated share repurchase. Investors tracking the story may watch how management commentary at these events updates on launch metrics, capital deployment, and any follow-up to recently filed executive compensation changes.

Key Figures

Guggenheim presentation: February 12, 2026 at 11:30 AM ET Oppenheimer presentation: February 26, 2026 at 10:00 AM ET TD Cowen presentation: March 4, 2026 at 9:50 AM ET

Guggenheim presentation

February 12, 2026 at 11:30 AM ET

Guggenheim Emerging Outlook: Biotech Summit 2026

Oppenheimer presentation

February 26, 2026 at 10:00 AM ET

Oppenheimer 36th Annual Healthcare Life Sciences Conference

TD Cowen presentation

March 4, 2026 at 9:50 AM ET

TD Cowen 46th Annual Health Care Conference

Historical Context

5 past events · Latest: Jan 12

5 events

1. Jan 12

   Prelim 2025 results

   24h Move

   -3.4%

   Preliminary 2025 revenues, VYKAT XR launch metrics, profitability and cash update.

2. Jan 05

   Pivotal study data

   24h Move

   -4.1%

   Publication of pivotal VYKAT XR randomized withdrawal data in PWS patients.

3. Dec 03

   Board member passing

   24h Move

   +3.9%

   Announcement of audit chair’s passing and expected change in committee leadership.

4. Nov 24

   Conference appearance

   24h Move

   +1.8%

   Planned CEO fireside chat at a major healthcare investor conference.

5. Nov 11

   ASR buyback

   24h Move

   +5.2%

   $100M accelerated share repurchase following achievement of profitability in Q3 2025.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in February and March:

Guggenheim Emerging Outlook: Biotech Summit 2026
Presentation Date: Thursday, February 12, 2026 at 11:30 AM ET
Presentation Format: Fireside Chat
Webcast: Here

Oppenheimer 36th Annual Healthcare Life Sciences Conference
Presentation Date: Thursday, February 26, 2026 at 10:00 AM ET
Presentation Format: Company presentation

TD Cowen 46th Annual Health Care Conference 
Presentation Date: Wednesday, March 4, 2026 at 9:50 AM ET
Presentation Format: Fireside Chat
Webcast: Here

Replay of the Guggenheim and TD Cowen events will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome and was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Soleno Therapeutics (SLNO) present at the Guggenheim Biotech Summit in 2026?

Soleno will present on Thursday, February 12, 2026 at 11:30 AM ET in a fireside chat. According to the company, the event will be webcast and a replay will be posted in the Investors section at www.soleno.life after the presentation.

What time and format is the SLNO presentation at Oppenheimer 36th Annual Healthcare Life Sciences Conference?

Soleno is scheduled to present on Thursday, February 26, 2026 at 10:00 AM ET as a company presentation. According to the company, investors can view the live presentation per conference arrangements and check the Investors section for any posted replay.

How can investors access Soleno Therapeutics' (SLNO) TD Cowen conference presentation replay?

A replay of the TD Cowen event will be available in the Investors section of www.soleno.life. According to the company, the TD Cowen presentation occurs Wednesday, March 4, 2026 at 9:50 AM ET and the replay will be posted after the live event.

Which Soleno (SLNO) conference presentations in Feb–Mar 2026 are fireside chats versus company presentations?

Soleno will host fireside chats on Feb 12, 2026 (Guggenheim) and Mar 4, 2026 (TD Cowen); the Feb 26, 2026 Oppenheimer session is a company presentation. According to the company, each session has its listed format and scheduled start time.

Where will Soleno Therapeutics (SLNO) post webcasts and replays for its February–March 2026 conferences?

Webcasts and replays will be posted in the Investors section at www.soleno.life. According to the company, live webcasts are provided for applicable events and replays will be made available after the Guggenheim and TD Cowen presentations.